Xylem Inc. XYL
Composite 50/100; the shares have moved about 26% annualised. Names that move more contribute more risk for the same amount invested, and our composite reflects how strong the evidence for this one is right now.
Momentum ranks 24/100 — a strong mark against it.
Balance-sheet strength ranks 79/100 — a strong point in its favour. Income ranks 53/100 — a slight point in its favour.
Momentum ranks 24/100 — a strong mark against it. Valuation ranks 45/100 — a slight mark against it. Growth ranks 47/100 — a slight mark against it.
What the company does Xylem Inc. designs, manufactures, and services engineered water solutions for utilities, industries, and buildings. Its portfolio spans pumps, filtration systems, smart meters, and analytics platforms under brands like Flygt, Sensus, and Goulds Water Technology.
Key financials Xylem’s trailing ROE is 9.2% and ROA 5.1%, with net margins at 11.2%. Revenue grew 5.5% and EPS 6.5%, supported by gross margins of 39.2%. Debt/equity is 0.29 and interest coverage 56.35x, indicating moderate leverage.
Stock health SiderAvia scores Xylem’s overall quality at 51.6/100 (weak quality, weak momentum). Momentum is negative over 6m (-13.97%) and 12m (-22.47%), with RSI(14) at 35.20.
Price vs fair value The stock trades at a **discount of 39.70%** versus the analyst mean target of 153.88. - Recent pump-market growth forecasts highlight long-term demand tailwinds (Europe Pump Market Research Report 2026-2031). - Competitive activity in hygienic pumps underscores industry dynamism (Atlas Copco acquisition of Pomac BV). - Post-earnings decline of 7.1% signals near-term investor caution (Xylem (XYL) Down 7.1% Since Last Earnings Report).
Looking forward Forward P/E of 20.16 and PEG of 0.61 suggest valuation support, while weak momentum (momentum score 28.7) tempers near-term outlook. Execution on integration and digital growth initiatives will be key.
This is not investment advice. Sideravia provides automated, data-driven analysis for information and education only. Nothing on this page is a personal recommendation or an invitation to buy or sell any security, and it does not consider your objectives or financial situation. Assessments are generated by rules applied uniformly to every covered stock — how our scores work.
Data as of 2026-09-03, compiled from third-party sources; errors and delays are possible and figures are not warranted. Investing puts your capital at risk; past performance does not predict future results. We publish our full track record, including the calls that lost, and our conflicts of interest.